308
Participants
Start Date
February 15, 2018
Primary Completion Date
January 21, 2021
Study Completion Date
January 21, 2021
Canagliflozin
Canagliflozin 100mg orally once daily
Placebo
Placebo orally once daily
Research site, Aichi
Research site, Chiba
Research site, Fukuoka
Research site, Fukushima
Research site, Gunma
Research site, Hiroshima
Research site, Hokkaido
Research site, Hyōgo
Research site, Ibaraki
Research site, Kagawa
Research site, Kagoshima
Research site, Kanagawa
Research site, Kumamoto
Research site, Mie
Research site, Nagano
Research site, Nagasaki
Research site, Okinawa
Research site, Osaka
Research site, Ōita
Research site, Saitama
Research site, Shizuoka
Research site, Tochigi
Research site, Tokyo
Research site, Wakayama
Research site, Yamagata
Research site, Yamaguchi
Lead Sponsor
Mitsubishi Tanabe Pharma Corporation
INDUSTRY